These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 17645586

  • 21. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T, Goto T, Hirai S, Kang MS, Uemura T, Yu R, Takahashi N.
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [Abstract] [Full Text] [Related]

  • 22. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F, Manciuc C, Grigore C, Foia L.
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [Abstract] [Full Text] [Related]

  • 23. An overview on biological mechanisms of PPARs.
    Kota BP, Huang TH, Roufogalis BD.
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.
    Guo L, Tabrizchi R.
    Pharmacol Ther; 2006 Jul; 111(1):145-73. PubMed ID: 16305809
    [Abstract] [Full Text] [Related]

  • 25. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J, Wójcicka G, Jamroz A.
    Postepy Hig Med Dosw; 2003 Jul; 57(2):199-217. PubMed ID: 12866356
    [Abstract] [Full Text] [Related]

  • 26. Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties.
    Li Y, Qi Y, Huang TH, Yamahara J, Roufogalis BD.
    Diabetes Obes Metab; 2008 Jan; 10(1):10-7. PubMed ID: 18095947
    [Abstract] [Full Text] [Related]

  • 27. PPAR agonists and the metabolic syndrome.
    Staels B.
    Therapie; 2007 Jan; 62(4):319-26. PubMed ID: 17983557
    [Abstract] [Full Text] [Related]

  • 28. PPAR gamma as a metabolic regulator: insights from genomics and pharmacology.
    Savage DB.
    Expert Rev Mol Med; 2005 Jan 25; 7(1):1-16. PubMed ID: 15673477
    [Abstract] [Full Text] [Related]

  • 29. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J, Delayre-Orthez C, Frossard N, Pons F.
    Fundam Clin Pharmacol; 2006 Oct 25; 20(5):429-47. PubMed ID: 16968414
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptors and acute lung injury.
    Cuzzocrea S.
    Curr Opin Pharmacol; 2006 Jun 25; 6(3):263-70. PubMed ID: 16580256
    [Abstract] [Full Text] [Related]

  • 31. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B.
    Arterioscler Thromb Vasc Biol; 2006 May 25; 26(5):977-86. PubMed ID: 16424352
    [Abstract] [Full Text] [Related]

  • 32. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M.
    Acta Physiol (Oxf); 2007 Nov 25; 191(3):171-88. PubMed ID: 17935522
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears.
    Mao Z, Ong AC.
    Nephron Clin Pract; 2009 Nov 25; 112(4):c230-41. PubMed ID: 19546582
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun 25; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 35. Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.
    Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ.
    Am J Ther; 2007 Jun 25; 14(1):49-62. PubMed ID: 17303976
    [Abstract] [Full Text] [Related]

  • 36. PPAR and Pain.
    Maeda T, Kishioka S.
    Int Rev Neurobiol; 2009 Jun 25; 85():165-77. PubMed ID: 19607969
    [Abstract] [Full Text] [Related]

  • 37. Therapeutical effects of PPAR agonists assessed by biomarker modulation.
    Chinetti-Gbaguidi G, Fruchart JC, Staels B.
    Biomarkers; 2005 Nov 25; 10 Suppl 1():S30-6. PubMed ID: 16298909
    [Abstract] [Full Text] [Related]

  • 38. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.
    Collino M, Patel NS, Thiemermann C.
    Ther Adv Cardiovasc Dis; 2008 Jun 25; 2(3):179-97. PubMed ID: 19124421
    [Abstract] [Full Text] [Related]

  • 39. Novel peroxisome proliferator activated receptor-alpha agonists.
    Fruchart JC.
    Am J Cardiol; 2007 Dec 03; 100(11 A):n41-6. PubMed ID: 18047852
    [Abstract] [Full Text] [Related]

  • 40. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH, Roufogalis BD.
    Curr Mol Pharmacol; 2012 Jun 03; 5(2):241-7. PubMed ID: 22122453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.